The association wasnt specific to any one particular antidepressant, although the researchers did note that it seemed stronger for Cymbalta (duloxetine)
Anyone looking to incorporate a scientifically-backed supplement into their wellness routine can benefit from this potent formulation
It mirrors the impact we have seen from statins, ace inhibitors, and beta-blockers in similar populations and generally those studies have had a longer treatment duration meaning that semaglutide could be a far superior intervention at the 5 year mark
Germanys growth reflects demand for evidence-based digital health services with strong data protection
Nothing extreme, but enough that I paid attention to it
A separate recent (2024) law review article that examined recent court cases also found that: There have been no examples of patent infringement lawsuits brought by drug manufacturers against compounding pharmacies that have reached trial or substantive judgments by courts. Most litigation against pharmacies compounding semaglutide during the shortage has focused on trademark law and unfair competition, the latter of which has included claims for deceptive business practices under state law and for false advertising under the Lanham Act (15 U.S.C
